Vaccine types explained: live, inactivated, conjugate and mRNA
Each vaccine platform shows the immune system an antigen in a different way. Match the type to the response it triggers, and see why live vaccines are avoided in immunodeficiency.
Explain the immune response each vaccine platform generates (live-attenuated, inactivated, subunit and toxoid, conjugate, mRNA) and why live vaccines are avoided in immunodeficiency.
The short version
- A vaccine is a rehearsal: it shows the immune system an antigen so that memory exists before the real infection.
- Live-attenuated vaccines replicate, giving a strong, durable response with cytotoxic T cells, but the weakened organism can replicate without control in an immunocompromised person.
- Inactivated, subunit and toxoid vaccines cannot replicate, so they are safe, but the response is often shorter-lived and boosters are needed.
- A bacterial capsule polysaccharide is a T-cell-independent antigen; a conjugate vaccine adds a carrier protein so T cells help and memory forms, even in infants.
- Avoid live vaccines in significant immunodeficiency and on immunosuppressants; non-live vaccines are safe, and any live vaccine needed should be given at least four weeks before the drug starts.
Same needle, opposite outcomes: why vaccine types matter
A toddler gets the measles vaccine. A fever, maybe a faint rash, then long-lasting protection. A child with no working T cells gets the same shot, and the weakened virus has nothing to stop it.[1][2]
The difference lies in the vaccine type. This lesson matches each vaccine platform to the immune response it triggers, and shows why live vaccines are avoided in immunodeficiency.
A vaccine is a rehearsal: the protein-antigen response
A vaccine shows the immune system an antigen, so that memory exists before the real infection.[1]
This is the pathway for a protein antigen. The adjuvant matters because danger signals are what activate the dendritic cell; the helper T cell then drives B-cell development.[1][3]
- Uptake and activationA dendritic cell takes up the protein antigen. Danger signals from the adjuvant switch the cell on.
- PresentationIn a lymph node it shows peptide on MHC class II to a helper T cell.
- B-cell helpThe helper T cell helps B cells.
- Memory and antibodyThe result is memory B cells and long-lived plasma cells making antibody.
For almost every routine vaccine, antibody is the main protection.[1]
Live-attenuated vaccines: replicate, strong and durable
Live-attenuated vaccines contain a weakened organism that still replicates: enough for a strong response, not enough for disease.[1][2]
Examples are measles, mumps, rubella, varicella, rotavirus, yellow fever, oral polio, BCG and the nasal influenza vaccine.[1][2]
Because live vaccines replicate inside host cells, they also engage the cell-mediated arm: CD8 effector T cells eliminate infected cells, and CD8 memory T cells respond quickly on later exposure.[1]
Replicating inside our cells, they copy a natural infection: many epitopes, a fast antibody response, memory, and cytotoxic T cells that clear infected cells. Protection is often long-lasting; yellow fever can last for life after one dose.[1][2]
Inactivated, subunit and toxoid vaccines: they cannot replicate
Inactivated vaccines contain killed whole organisms, such as the Salk polio vaccine. They cannot replicate, so they are safe, but the response is often shorter-lived, so boosters are needed, and some add an adjuvant.[1][2]
| Platform | What it contains | Example |
|---|---|---|
| Inactivated | Killed whole organism | Salk polio vaccine |
| Subunit: purified protein | A purified piece of the organism | Acellular pertussis |
| Subunit: recombinant protein | A protein made by recombinant methods | Hepatitis B |
| Subunit: virus-like particle | A particle without the genome | HPV |
| Toxoid | A formaldehyde-inactivated toxin | Tetanus, diphtheria |
Toxoid vaccines, tetanus and diphtheria, are formaldehyde-inactivated toxins. Subunit vaccines use only pieces of the organism, so there is no whole organism to replicate.[1][2]
Sugar capsules and conjugate vaccines
The capsule sugar of a bacterium, a polysaccharide, is a T-cell-independent antigen: no T-cell help, so no memory, and a poor response in infants.[1][4]
A conjugate vaccine links the sugar to a carrier protein, such as tetanus toxoid. T cells recognise the protein and help the B cell, so memory forms, even in infants.[1][4]
That is how conjugate vaccines protect against encapsulated bacteria: pneumococcus, Haemophilus influenzae type b and meningococcus.[1][4]
mRNA vaccines: not live, made inside our cells
mRNA vaccines deliver messenger RNA inside a lipid nanoparticle. Our own cells translate it into the antigen.[3]
Made inside the cell, the antigen is shown on MHC class I to CD8 T cells, and on class II to CD4 T cells, while B cells make antibody.[3]
It is not live: it cannot replicate, and the mRNA does not integrate into host DNA.[3]
Live vaccines and immunosuppressive drugs: which vaccines, when
Take a patient about to start an immunosuppressive drug. For polio, give the inactivated vaccine, not the live oral one. For measles, MMR is live, so once treatment has started it is contraindicated.[2] If it is needed, give it at least four weeks before the drug begins.
| Type | Can it replicate? | In immunodeficiency |
|---|---|---|
| Live-attenuated | Yes | Avoided |
| Inactivated, subunit, toxoid, conjugate | No | Safe, but may not protect if B cells or T cells are missing |
| mRNA | No | Not live, so no replication risk |
Practice question
Original · USMLE styleA 2-month-old boy has persistent oral thrush, chronic diarrhoea and poor weight gain. Flow cytometry confirms severe combined immunodeficiency. He is brought in for his routine 2-month vaccines.
Common questions
What are the main vaccine types?
Live-attenuated, inactivated (killed whole organism), subunit (purified protein, recombinant protein or virus-like particle), toxoid, conjugate and mRNA vaccines.
Why are live vaccines avoided in immunodeficiency?
A live-attenuated vaccine contains a weakened organism that still replicates. In an immunocompromised person it can replicate without control, so live vaccines are avoided in significant immunodeficiency and on immunosuppressants.
What is a conjugate vaccine?
A conjugate vaccine links a bacterial capsule sugar to a carrier protein such as tetanus toxoid. T cells recognise the protein and help the B cell, so memory forms, even in infants.
Is an mRNA vaccine a live vaccine?
No. It cannot replicate, and the mRNA does not integrate into host DNA. Our own cells translate it into the antigen.
When should a live vaccine be given before an immunosuppressive drug?
If a live vaccine is needed, give it at least four weeks before the drug begins. Once immunosuppressive treatment has started, live vaccines such as MMR are generally contraindicated.
Transcript
Read the full narration, by chapter700 words
0:00Same needle, opposite outcomes
A toddler gets the measles vaccine. A fever, maybe a faint rash, then long-lasting protection. A child with no working T cells gets the same shot, and the weakened virus has nothing to stop it. Same needle, opposite outcomes. Why? Today: match each vaccine type to the response it triggers, and see why live vaccines are avoided in immunodeficiency. A vaccine is a rehearsal:
0:26A vaccine is a rehearsal: the protein-antigen response
it shows the immune system an antigen, so memory exists before the real infection. For a protein antigen, a dendritic cell takes it up, and danger signals from the adjuvant switch the cell on. In a lymph node it shows peptide on MHC class two to a helper T cell, which then helps B cells. The result is memory B cells and long-lived plasma cells making antibody. For almost every routine vaccine, antibody is the main protection.
0:58Live-attenuated vaccines: replicate, strong and durable
Live-attenuated vaccines contain a weakened organism that still replicates: enough for a strong response, not enough for disease. Measles, mumps, rubella, varicella, rotavirus, yellow fever, oral polio, BCG, and the nasal influenza vaccine. Replicating inside our cells, they copy a natural infection: lots of epitopes, a fast antibody response, memory, and cytotoxic T cells that clear infected cells. Protection is often long-lasting; yellow fever can last for life after one dose. The price: in an immunocompromised person, the weakened organism can replicate without control.
1:43Inactivated vaccines: killed, safe, shorter-lived
Inactivated vaccines contain killed whole organisms, such as the Salk polio vaccine. They cannot replicate, so they are safe, but the response is often shorter-lived, so boosters are needed, and some add an adjuvant.
1:59Subunit and toxoid vaccines
Subunit vaccines use only pieces: purified protein, like acellular pertussis, recombinant protein, like hepatitis B, or virus-like particles, like H PV. Toxoid vaccines, tetanus and diphtheria, are formaldehyde-inactivated toxins. The capsule sugar of a bacterium,
2:18Sugar capsules and conjugate vaccines
a polysaccharide, is a T-cell-independent antigen: no T-cell help, so no memory, and a poor response in infants. A conjugate vaccine links the sugar to a carrier protein, such as tetanus toxoid. T cells recognise the protein and help the B cell, so memory forms, even in infants. That is how conjugate vaccines protect against encapsulated bacteria: pneumococcus, Haemophilus influenzae type b, and meningococcus.
2:51mRNA vaccines: not live, made inside our cells
mRNA vaccines deliver messenger RNA inside a lipid nanoparticle. Our own cells translate it into the antigen. Made inside the cell, it is shown on MHC class one to CD eight cells, and on class two to CD four cells, while B cells make antibody. It is not live: it cannot replicate, and the mRNA does not integrate into host DNA.
3:19Before an immunosuppressive drug: which vaccines, when
Now a patient about to start an immunosuppressive drug. Polio: give the inactivated vaccine, not the live oral one. Measles: MMR is live, so once treatment has started it is contraindicated; if it is needed, give it at least four weeks before the drug begins. The rule: avoid live vaccines in significant immunodeficiency and on immunosuppressants. Non-live vaccines are safe, though they may not protect when B cells or T cells are missing.
3:52Your turn: a practice question
Your turn. A two-month-old boy has persistent oral thrush, chronic diarrhoea and poor weight gain. Flow cytometry confirms severe combined immunodeficiency. He is brought in for his routine two-month vaccines. Which of the following vaccines should be withheld? A, inactivated polio vaccine. B, recombinant hepatitis B vaccine. C, oral rotavirus vaccine. D, pneumococcal conjugate vaccine. E, diphtheria, tetanus and acellular pertussis vaccine.
4:28Pause, then rule out the options
Pause here and decide. A is out: killed poliovirus cannot replicate, so it is not a danger, even if the response may be weak. B is out: recombinant protein cannot replicate either. D is out: a conjugate is a sugar on a carrier protein, with nothing live in it. E is out: toxoids and purified protein cannot replicate.
4:55The answer: oral rotavirus vaccine
So the answer is C. Rotavirus vaccine is live, and in severe combined immunodeficiency the weakened virus can replicate unchecked.
5:06Recap pocket card
Three things to keep. One: live vaccines replicate, giving strong, durable immunity with T-cell help, but are avoided in immunodeficiency. Two: non-live vaccines cannot replicate; conjugates recruit T cells by a protein carrier, and mRNA is made inside our cells. Three: bring vaccines up to date before an immunosuppressive drug starts, with any live one at least four weeks ahead. That is vaccines, and when to hold them.
Sources
Numbers in the text, e.g. [1], point here- A guide to vaccinology: from basic principles to new developments. 2021. europepmc.org/article/PMC/PMC7754704
- Vaccinations in patients with immune-mediated inflammatory diseases. 2010. europepmc.org/article/PMC/PMC2936949
- A Comprehensive Review of mRNA Vaccines. 2023. europepmc.org/article/PMC/PMC9917162
- Vaccines Through Centuries: Major Cornerstones of Global Health. 2015. europepmc.org/article/PMC/PMC4659912
- Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane review, 2021. europepmc.org/article/PMC/PMC8597890
The practice question is original and its patient is synthetic. Every fact is checked against the sources above in independent accuracy reviews. Always follow your local guidelines and your own laboratory’s ranges.
Image credits. Illustrations: Servier Medical Art (smart.servier.com), CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/), adapted (recoloured, outlined, resized): lymph node, bacterium. NIAID NIH BioArt (public domain): dendritic cell, T cell, CD8 T cell, antibody, vaccine vial, enveloped virus. Bioicons, B cell and plasma cell by El-Jayawant (CC BY 4.0). Health Icons (CC0): syringe, baby, measles face. The lipid nanoparticle, mRNA, ribosome, proteasome, MHC, graphs, drug timeline, question card, pocket card and all handwriting are drawn in code (original). No AI-generated teaching images.
Corrections. None so far. Spotted an error? Email info@medservatory.com with the lesson code MS-S1-IMM-013.
For exam study only, not medical advice. Read the medical disclaimer.
In this series
Playlist on YouTube- EP 01MHC I vs MHC II: how antigen presentation works5:03
- EP 02T-cell activation: the two-signal model4:58
- EP 03Th1, Th2, Th17 and Treg: helper T-cell subsets5:13
- EP 04Antibody isotypes and class switching5:13
- EP 05Central vs peripheral tolerance: how lymphocytes learn self-tolerance5:26
- EP 06Complement system explained: three pathways, one ending5:24
- EP 07Complement deficiencies: C1q, C3, C5–C9 and C1 inhibitor5:15
- EP 08Hypersensitivity types I to IV: the four effectors5:20
- EP 09B-cell vs T-cell immunodeficiency: predict the infections5:24
- EP 10Hyper IgM syndrome: CD40 ligand and class switching5:19
- EP 11Chronic granulomatous disease: NADPH oxidase and the respiratory burst5:20
- EP 12Leukocyte adhesion deficiency: CD18 and neutrophil extravasation5:01
- EP 13Transplant rejection explained: hyperacute, acute, chronic and GVHD5:51
- EP 14Vaccine types explained: live, inactivated, conjugate and mRNA5:41